Company Filing History:
1 out of 12,160 
1 out of 1,209 
1 out of 443 
Years Active: 2025
Title: Katarzyna Handing: Innovator in Pharmaceutical Compounds
Introduction
Katarzyna Handing is a notable inventor based in Framingham, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as inhibitors for specific kinases. Her work is crucial for advancing treatments for proliferative disorders.
Latest Patents
Katarzyna holds a patent for a compound described as 3-amino-2-[2-(acylamino)pyridin-4-yl]-1,5,6,7-tetrahydro-4h-pyrrolo[3,2-c]pyridin-4-one, which functions as a CSNK1 inhibitor. This invention relates to processes for producing these compounds and their applications as pharmaceuticals. The compounds are specifically designed to inhibit Casein kinase 1 alpha and/or delta (CSNK1α and/or β), which are valuable in treating various proliferative disorders. She has been granted 1 patent for her innovative work.
Career Highlights
Throughout her career, Katarzyna has worked with prominent organizations, including Bayer Aktiengesellschaft and Dana-Farber Cancer Institute Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Katarzyna has collaborated with notable colleagues such as Volker Schulze and Anne Mengel. These partnerships have enhanced her research and development efforts, leading to significant advancements in her field.
Conclusion
Katarzyna Handing is a distinguished inventor whose work in pharmaceutical compounds has the potential to impact the treatment of proliferative disorders significantly. Her innovative contributions and collaborations highlight her importance in the scientific community.